Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Biomarker group Immune system alteration Cytokines Chemokines and their receptors Myelin Antibodies Complement-related biomarkers Cell-cycle and apoptosis markers Cerebrospinal Fluid oligoclonal bands Blood-brain barrier damage Astrocytic protein Matrix Metalloproteases /their inhibitors Integral proteins Name IL-1, IL-2 ,,IL-6, TNF-a, TGF-β CCR5 , CC2/CCL2 anti-myelin-basic protein a-MBP anti-MOG antibody C3 , C4 activated neo-C9 FAS, FAS-L, BCL-2, TRAIL Presence Reference Peripheral blood Peripheral blood CSF CSF Peripheral blood (1, 2) (3, 4) (1) CSF (3) S100β MMP , TIMP Thrombomodulin CSF CSF CSF (4) (1) Calpain, Pepsin MBP-gliotoxin , QYNAD Peripheral blood CSF (1) Nitric Oxide and their stable metabolites NO NO2, NO3 CSF and Peripheral blood Neuronal damage Cytoskeleton and microtubule-associated proteins Biomarkers of gliosis TAU protein Actin Tubulin CSF GFAP CACY, CAPL, S100L//β CSF and Peripheral blood CSF NCAM CPK-BB NSE CSF CSF CSF Demyelination Proteolytic enzymes Gliotoxins Markers of oxidative stress Glial Fibrillary Acidic Protein S100 proteins Remyelination and repair Neural cell adhesive molecules Creatinine Phosphokine izoenzymes neural-specific enolase (5) (1) (1) (2, 5) (1) Supplementary Table 1. MS biomarkers. References 1. 2. 3. 4. 5. 6. Bielekova B & Martin R (2004) Development of biomarkers in multiple sclerosis Brain 127, 1463-1478. Lassmann H & Ransohoff RM (2004) The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal Trends Immunol 25, 132-137. Williams KC, Ulvestad E, & Hickey WF (1994) Immunology of multiple sclerosis Clin Neurosci 2, 229-245. Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, et al. (2004) Peripheral markers of blood-brain barrier damage Clin Chim Acta 342, 1-12. Giovannoni G, Miller DH, Losseff NA, Sailer M, Lewellyn-Smith N, et al. (2001) Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis J Neurol 248, 487-495. H.H. Roenigh & Maibach HI (1985) Psoriasis ( Marcel Dekker, New York, Basel).